Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication
Condition(s):Helicobacter Pylori Infection; Chronic GastritisLast Updated:January 31, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Helicobacter Pylori Infection; Chronic GastritisLast Updated:January 31, 2023Completed
Condition(s):Helicobacter Pylori InfectionLast Updated:October 18, 2022Recruiting
Condition(s):Helicobacter Pylori InfectionLast Updated:February 14, 2023Not yet recruiting
Condition(s):Foot Ulcer, DiabeticLast Updated:March 23, 2015Terminated
Condition(s):NAFLD; NASH – Nonalcoholic SteatohepatitisLast Updated:February 3, 2021Unknown status
Condition(s):Safety; ToleranceLast Updated:September 26, 2023Completed
Condition(s):Helicobacter Pylori InfectionLast Updated:August 9, 2022Not yet recruiting
Condition(s):Kidney Stones; NephrolithiasisLast Updated:February 1, 2024Recruiting
Condition(s):Peptic Ulcer DiseaseLast Updated:May 11, 2020Unknown status
Condition(s):the Eradication Rates of Helicobacter PyloriLast Updated:December 19, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.